Actively Recruiting
Adaptive Decision Support for Addiction Treatment (ADAPT) Serial Randomized Testing for Usability, Round 1
Led by Yale University · Updated on 2026-05-05
300
Participants Needed
3
Research Sites
60 weeks
Total Duration
On this page
Sponsors
Y
Yale University
Lead Sponsor
N
National Institute on Drug Abuse (NIDA)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study is stage 2, round 1 of a larger study which refines and optimizes the EMBED clinical decision support (CDS); see NCT03658642 to increase number of ED physicians following standard of care for the administration of buprenorphine to appropriate patients with opioid use disorder.
CONDITIONS
Official Title
Adaptive Decision Support for Addiction Treatment (ADAPT) Serial Randomized Testing for Usability, Round 1
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Emergency department patient
- 18 years of age or older
- Moderate to severe opioid use disorder
You will not qualify if you...
- Under 18 years of age
- Pregnant
- Currently receiving medication for opioid use disorder
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Yale New Haven Shoreline Medical Center
Guilford, Connecticut, United States, 06437
Actively Recruiting
2
Yale New Haven Hospital- St. Raphael
New Haven, Connecticut, United States, 06510
Actively Recruiting
3
Yale New Haven Hospital
New Haven, Connecticut, United States, 06510
Actively Recruiting
Research Team
E
Edward Melnick, MD, MHS
CONTACT
L
Laurel Buchanan, MA
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
SEQUENTIAL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here